12 unknown. 12 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Unknown 12 |
| Phase 2 | 4 | Unknown 4 |
Follow Disease: new trials by email Literature Review of Disease trials Research Report on Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction platelet-rich plasma combined with hyaluronic acid, Zinc Gluconate 10 MG Oral Tablet, 4 bottles of phenyl ethyl alcohol, lemon, eucalyptus, and clove oil - Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis), Effect of Drug | Phase 3 | Unknown | Taichung Veterans General Hospital | 80 | 2024-03-20 | 2024-03-04 |
| Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study Aveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection - Muscle Atrophy, Surgery | Phase 2 / Phase 3 | Unknown | The Stone Research Foundation for Sports Medicine and Arthritis | 15 | 2020-05-08 | 2021-08-31 |
| IgM-Enriched Immunoglobulin for Neonatal Sepsis IgM-enriched IVIG - Neonatal Sepsis, Early-Onset, Very Low Birth Weight Infant | Phase 3 | Unknown | Fakultas Kedokteran Universitas Indonesia | 70 | 2019-09-01 | 2019-08-01 |
| Schistosomiasis Diagnosis Using a CAA Antigen Test Praziquantel, UCP-LF CAA, composite diagnostic - Schistosomiasis Hematobium, Diagnostic | Phase 3 | Unknown | Centre de Recherche Médicale de Lambaréné | 100 | 2019-05-01 | 2021-07-27 |
| Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT Decitabine, Busulfan (BU), Cyclophosphamide (CY) - Allogeneic Hematopoietic Stem Cell Transplantation, Conditions | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 122 | 2018-07-01 | 2018-07-24 |
| Study Assessing Hybrid SPECT-CT With Labeled Leukocytes for Diagnosis of Vascular Prosthesis Infections 99mTc-Exametazime (HMPAO)-labeled leukocytes - Vascular Prosthesis Infection | Phase 3 | Unknown | University Hospital, Angers | 80 | 2015-09-01 | 2019-03-07 |
| Study of EBI-005 in Dry Eye Disease (DED) EBI-005, Placebo - Dry Eye | Phase 3 | Unknown | Eleven Biotherapeutics | 188 | 2015-04-01 | 2015-06-04 |
| Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome benralizumab, Placebo - Respiratory System Agents, Anti-Asthmatic Agents | Phase 2 / Phase 3 | Unknown | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2014-05-19 | 2022-02-08 |
| Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon Daflon, Venaflon (Diosmin and Hesperidin) - Chronic Venous Insufficiency, Disease | Phase 3 | Unknown | Laboratório Teuto Brasileiro S/A | 82 | 2012-02-01 | 2011-11-22 |
| Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor 123 I - ALTROPANE® - Parkinsonian Syndromes | Phase 3 | Unknown | Alseres Pharmaceuticals, Inc | 240 | 2010-07-01 | 2010-02-03 |
| The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing TRUS probe - Prostate Cancer | Phase 3 | Unknown | Amphia Hospital | 800 | 2009-10-01 | 2011-06-22 |
| Dementia Early Recognition and Response in Primary Care Educational Dementia training - Dementia | Phase 2 / Phase 3 | Unknown | University College, London | 125 | 2009-07-01 | 2010-04-19 |
Dementia (1) · Drug-Related Side Effects and Adverse Reactions (1) · Dry Eye Syndromes (1) · Eosinophilia (1) · Eosinophilic Esophagitis (1) · Essential Tremor (1) · Hematologic Diseases (1) · Inflammation (1) · Knee Injuries (1) · Leukocyte Disorders (1) · Muscular Atrophy (1) · Neonatal Sepsis (1) · Parkinson Disease (1) · Parkinsonian Disorders (1)
Pathological Conditions, Signs and Symptoms (12) · Pathologic Processes (11) · Nervous System Diseases (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Infections (2) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Atrophy (1) · Basal Ganglia Diseases (1) · Chemically-Induced Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Dyskinesias (1)
Busulfan (1) · Cyclophosphamide (1) · Decitabine (1) · Diosmin (1) · EBI-005 (1) · Hesperidin (1) · Hyaluronic Acid (1) · Injections, Intramuscular (1) · Praziquantel (1) · Saline Solution (1) · Tablets (1) · Testosterone Propionate (1) · Zinc (1) · benralizumab (1) · gluconic acid (1)
Alseres Pharmaceuticals, Inc (1) · Amphia Hospital (1) · Centre de Recherche Médicale de Lambaréné (1) · Eleven Biotherapeutics (1) · Fakultas Kedokteran Universitas Indonesia (1) · Laboratório Teuto Brasileiro S/A (1) · Nanfang Hospital, Southern Medical University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Taichung Veterans General Hospital (1) · The Stone Research Foundation for Sports Medicine and Arthritis (1) · University College, London (1) · University Hospital, Angers (1)
United States (4) · China (1) · France (1) · Gabon (1) · Netherlands (1) · Taiwan (1) · United Kingdom (1)
Amy D Klion, M.D. (1) · Andrea Kreidenweiss, PhD (1) · Jane Wilcock, MA(hons) MSc (1) · Mani Vessal, Ph.D. (1) · Michael Goldstein, MD (1) · Nina D Putri, MD, PhD (1) · Qifa Liu (1) · Rinawati Rohsiswatmo, MD, PhD (1) · Rong-San Jiang, MD, PhD (1) · Stijn Roemeling, MD, PhD (1)
PMID 20146803, PMID 24257429, PMID 32993559, PMID 35283330, PMID 40120806
2015 (1)